Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Study on in Vivo CAR-T Therapy Targeting CD20 for the Treatment of Hematological Malignancies

NCT07362602 is registered in ClinicalTrials.gov with The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army as lead sponsor.

NCT NCT07362602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07362602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Study on in Vivo CAR-T Therapy Targeting CD20 for the Treatment of Hematological Malignancies
Lead sponsor
The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army
Phase
Phase 1
Overall status
Not yet recruiting
Start date
January 26, 2026
Completion date
December 31, 2028
Enrollment
47 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hematological malignancies